INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 453m ago
HOUSE PTR52m ago
SEC 13F52m ago
ROBINHOOD CHAIN52m ago
MN
Corporate insider

Martin Christopher Nathan

DirectorCIK 0002097992

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score19
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
MN
Martin Christopher NathanDirector
EWTXEdgewise Therapeutics, Inc.
Grant or award
A—
16.4K sh
Jun 5, 2026Jun 16, 2026
traded Jun 5, 2026
+11dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Edgewise Therapeutics, Inc.Director · Nov 24, 2025
15
MN
Martin Christopher NathanDirector
EWTXEdgewise Therapeutics, Inc.
Grant or award
A
—
45.1K sh
Nov 19, 2025
Nov 24, 2025
traded Nov 19, 2025
+5d
SEC FORM 4

Evidence